دورية أكاديمية
أعرض في EDS

Challenging perspectives on the cellular origins of lymphoma.

التفاصيل البيبلوغرافية
العنوان: Challenging perspectives on the cellular origins of lymphoma.
المؤلفون: Malcolm TI; Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Lab Block Level 3, Box 231, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK., Hodson DJ; Department of Haematology, University of Cambridge, Cambridge, UK., Macintyre EA; Hematology and INSERM1151, Institut Necker-Enfants Malades, Université Sorbonne Paris Cité at Descartes and Assistance Publique-Hôpitaux de Paris, Paris 75743 Cedex 15, France., Turner SD; Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Lab Block Level 3, Box 231, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK sdt36@cam.ac.uk.
المصدر: Open biology [Open Biol] 2016 Sep; Vol. 6 (9).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Royal Society Pub Country of Publication: England NLM ID: 101580419 Publication Model: Print Cited Medium: Internet ISSN: 2046-2441 (Electronic) Linking ISSN: 20462441 NLM ISO Abbreviation: Open Biol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: London : Royal Society Pub., [2011]-
مستخلص: Both B and T lymphocytes have signature traits that set them apart from other cell types. They actively and repeatedly rearrange their DNA in order to produce a unique and functional antigen receptor, they have potential for massive clonal expansion upon encountering antigen via this receptor or its precursor, and they have the capacity to be extremely long lived as 'memory' cells. All three of these traits are fundamental to their ability to function as the adaptive immune response to infectious agents, but concurrently render these cells vulnerable to transformation. Thus, it is classically considered that lymphomas arise at a relatively late stage in a lymphocyte's development during the process of modifying diversity within antigen receptors, and when the cell is capable of responding to stimulus via its receptor. Attempts to understand the aetiology of lymphoma have reinforced this notion, as the most notable advances to date have shown chronic stimulation of the antigen receptor by infectious agents or self-antigens to be key drivers of these diseases. Despite this, there is still uncertainty about the cell of origin in some lymphomas, and increasing evidence that a subset arises in a more immature cell. Specifically, a recent study indicates that T-cell lymphoma, in particular nucleophosmin-anaplastic lymphoma kinase-driven anaplastic large cell lymphoma, may originate in T-cell progenitors in the thymus.
(© 2016 The Authors.)
References: Clin Exp Rheumatol. 2005 Nov-Dec;23(6):888-90. (PMID: 16396711)
Science. 1983 Feb 25;219(4587):963-7. (PMID: 6401867)
Leukemia. 2009 Nov;23(11):2129-38. (PMID: 19657361)
Oncology. 2004;66(6):476-80. (PMID: 15452377)
Nature. 1992 May 14;357(6374):161-4. (PMID: 1579166)
Blood. 2015 May 21;125(21):3287-96. (PMID: 25784678)
Annu Rev Immunol. 1994;12:117-39. (PMID: 8011279)
Leukemia. 2008 Mar;22(3):608-19. (PMID: 18046443)
Curr Immunol Rev. 2013 Feb;9(1):13-22. (PMID: 23853604)
Crit Rev Oncol Hematol. 2011 Sep;79(3):330-43. (PMID: 21273093)
Oncogene. 2003 Oct 30;22(49):7750-61. (PMID: 14586401)
Blood. 2008 Sep 15;112(6):2278-86. (PMID: 18566328)
Nat Rev Immunol. 2015 Mar;15(3):137-48. (PMID: 25656706)
Science. 1994 Mar 4;263(5151):1281-4. (PMID: 8122112)
Nat Rev Immunol. 2006 Feb;6(2):107-16. (PMID: 16491135)
Semin Arthritis Rheum. 1984 Nov;14(2):77-105. (PMID: 6399627)
Blood. 2004 Jun 15;103(12):4389-95. (PMID: 14962897)
Clin Exp Immunol. 1972 Feb;10(2):199-221. (PMID: 4625796)
Mol Cell Biol. 1997 Apr;17(4):2312-25. (PMID: 9121481)
Am J Pathol. 2013 Dec;183(6):1971-80. (PMID: 24404580)
Adv Pathobiol. 1976;(5):5-17. (PMID: 220858)
Oncogene. 2004 Aug 23;23(38):6524-34. (PMID: 15322522)
Blood. 2000 Nov 15;96(10):3578-84. (PMID: 11071657)
Blood. 2016 Mar 10;127(10):1287-96. (PMID: 26738536)
J Clin Pathol. 1995 May;48(5):395-7. (PMID: 7629280)
Oncologist. 2006 Jul-Aug;11(7):831-40. (PMID: 16880242)
Am J Surg Pathol. 2013 Sep;37(9):1456-7. (PMID: 24076779)
Blood. 2003 Mar 1;101(5):1919-27. (PMID: 12424201)
N Engl J Med. 1978 Nov 30;299(22):1215-20. (PMID: 309554)
Br J Haematol. 2010 Jun;149(5):653-68. (PMID: 19961482)
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2069-77. (PMID: 17119030)
Blood. 2003 Oct 1;102(7):2642-4. (PMID: 12816858)
Crit Rev Oncol Hematol. 2013 Dec;88(3):680-95. (PMID: 23972664)
J Exp Med. 2005 Feb 21;201(4):545-54. (PMID: 15710653)
J Immunol. 2000 Aug 1;165(3):1236-42. (PMID: 10903721)
Blood. 1991 Apr 1;77(7):1508-15. (PMID: 2009370)
Int J Clin Exp Pathol. 2011 Jan 30;4(2):124-33. (PMID: 21326808)
Cold Spring Harb Perspect Med. 2014 Feb 01;4(2):null. (PMID: 24492847)
Nat Commun. 2015 Jan 14;6:6025. (PMID: 25586472)
Nat Rev Cancer. 2004 Aug;4(8):644-53. (PMID: 15286744)
J Clin Pathol. 2007 Dec;60(12):1373-7. (PMID: 18042693)
Cancer Res. 1992 Oct 1;52(19 Suppl):5465s-5467s. (PMID: 1327508)
Philos Trans R Soc Lond B Biol Sci. 2001 Jan 29;356(1405):73-82. (PMID: 11205334)
J Immunol. 2013 Dec 15;191(12):6200-7. (PMID: 24218456)
Blood. 1999 Sep 15;94(6):1855-63. (PMID: 10477714)
Nat Rev Immunol. 2011 Jun 24;11(7):469-77. (PMID: 21701522)
J Clin Oncol. 2011 Dec 10;29(35):4669-76. (PMID: 22084369)
J Exp Med. 2010 May 10;207 (5):1031-44. (PMID: 20439541)
Anticancer Res. 2005 Sep-Oct;25(5):3191-6. (PMID: 16101126)
J Biol Chem. 2009 Sep 25;284(39):26871-81. (PMID: 19535334)
Blood Rev. 2007 Jul;21(4):201-16. (PMID: 17512649)
Arthritis Rheum. 2002 Aug;46(8):2160-71. (PMID: 12209521)
Blood. 2012 Apr 19;119(16):3659-67. (PMID: 22337721)
Anticancer Res. 2006 Sep-Oct;26(5A):3275-9. (PMID: 17094440)
Genes Chromosomes Cancer. 2001 Jul;31(3):248-54. (PMID: 11391795)
Blood. 2012 Aug 2;120(5):1048-59. (PMID: 22723554)
Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9964-9. (PMID: 16766651)
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5262-6. (PMID: 8506375)
Autoimmun Rev. 2010 Feb;9(4):203-6. (PMID: 19602455)
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18698-703. (PMID: 19837692)
Leukemia. 2016 May;30(5):1062-70. (PMID: 26719098)
Nature. 2010 Jan 7;463(7277):88-92. (PMID: 20054396)
Nat Rev Immunol. 2006 Feb;6(2):117-26. (PMID: 16491136)
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11977-82. (PMID: 21715655)
Oncogene. 2001 Sep 10;20(40):5580-94. (PMID: 11607811)
Lancet. 1999 Oct 30;354(9189):1499-503. (PMID: 10551495)
Blood. 2011 Feb 10;117(6):1781-91. (PMID: 21148333)
Oncogene. 2015 Apr 2;34(14):1843-52. (PMID: 24814516)
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13447-54. (PMID: 26483459)
Biochem Biophys Res Commun. 2009 Dec 18;390(3):892-6. (PMID: 19850008)
Blood. 1996 Nov 15;88(10):4005-11. (PMID: 8916967)
Leukemia. 2012 Jan;26(1):188-90. (PMID: 21836614)
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2463-8. (PMID: 9482908)
N Engl J Med. 1994 May 5;330(18):1267-71. (PMID: 8145781)
Curr Top Microbiol Immunol. 2015;390(Pt 1):267-85. (PMID: 26424650)
Cancer Res. 2009 Nov 15;69(22):8611-9. (PMID: 19887607)
Blood. 2011 Dec 22;118(26):6881-92. (PMID: 22042699)
J Exp Med. 2014 Aug 25;211(9):1821-32. (PMID: 25135298)
Lancet. 1993 Sep 4;342(8871):575-7. (PMID: 8102719)
J Clin Invest. 2011 Oct;121(10 ):3834-45. (PMID: 21926465)
Oncogene. 2002 Mar 14;21(12):1922-7. (PMID: 11896625)
J Exp Med. 2001 Dec 3;194(11):1625-38. (PMID: 11733577)
Am J Clin Pathol. 2008 Oct;130(4):613-9. (PMID: 18794055)
Leuk Res. 1989;13(2):103-16. (PMID: 2538681)
Plast Reconstr Surg. 2015 Feb;135(2):319-29. (PMID: 25383716)
J Clin Invest. 2007 Mar;117(3):823-34. (PMID: 17304354)
Cell Signal. 2007 Apr;19(4):740-7. (PMID: 17110082)
Trends Immunol. 2010 Aug;31(8):303-10. (PMID: 20634137)
Cancer Res. 2009 May 15;69(10):4175-83. (PMID: 19435902)
Cell. 2004 Jan 23;116(2):299-311. (PMID: 14744439)
J Pathol. 1996 Feb;178(2):122-7. (PMID: 8683376)
Blood. 1997 Oct 15;90(8):2901-10. (PMID: 9376569)
Cancer Cell. 2015 Apr 13;27(4):516-32. (PMID: 25873174)
Blood. 1985 Oct;66(4):848-58. (PMID: 3876124)
Nat Rev Cancer. 2003 Sep;3(9):639-49. (PMID: 12951583)
Mutat Res Rev Mutat Res. 2014 Oct-Dec;762:123-32. (PMID: 25475421)
Leukemia. 2005 Jul;19(7):1128-34. (PMID: 15902287)
Haematologica. 2010 Mar;95(3):449-55. (PMID: 19951975)
Am J Pathol. 2001 Jun;158(6):2185-93. (PMID: 11395396)
Blood. 2004 Nov 15;104(10):3358-60. (PMID: 15297316)
Nat Commun. 2016 Jan 12;7:10087. (PMID: 26753883)
Cancer Res. 2009 Oct 15;69(20):8094-101. (PMID: 19789351)
معلومات مُعتمدة: MC_PC_12009 United Kingdom MRC_ Medical Research Council; MR/M008584/1 United Kingdom MRC_ Medical Research Council
فهرسة مساهمة: Keywords: T cell; anaplastic large cell lymphoma; lymphomagenesis
تواريخ الأحداث: Date Created: 20160930 Latest Revision: 20220131
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC5043587
DOI: 10.1098/rsob.160232
PMID: 27683157
قاعدة البيانات: MEDLINE
الوصف
تدمد:2046-2441
DOI:10.1098/rsob.160232